Drug Development

Articles

Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

Week Of April 26, 2010: Company And People Notes: Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Society of Chemical Manufacturers and Affiliates is raising concerns over a recently introduced bill in the US Senate, which seeks to reform the Toxic Substances Control Act.

SOCMA Raises Concerns about Toxic-Substances Reform Bill

FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Week Of April 19, 2010: Company And People Notes: FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the April 2010 edition from Camfil Farr and K-Tron.

April 2010 Editor's Picks: Products from Camfil Farr and K-Tron

Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

Week of April 12, 2010: Company and People Notes: Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

Week Of April 5, 2010: Company And People Notes: Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

As the industry continues to evolve, do we know where we're headed?

Unconventional Communication

The authors examined the disintegration and dissolution profiles of propranolol and rofecoxib tablets overencapsulated with standard hard-gelatin capsules and with capsules specifically designed for double-blind clinical trials.

The Effect of Overencapsulation on Disintegration and Dissolution

Jane Wan is a freelance writer based in Singapore.

As demand for global vaccine development and production grows, all eyes are turning to Asia.

Ingredients